We have located links that may give you full text access.
Journal Article
Research Support, Non-U.S. Gov't
Long term results after Nissen fundoplication and Belsey Mark IV operation in patients with reflux oesophagitis and stricture.
This retrospective study was undertaken to compare long term results of Nissen fundoplication and the Belsey Mark IV repair in patients with reflux oesophagitis and stricture between 1972 and 1987. 105 patients were operated on for reflux oesophagitis, and 43 of the patients had stricture. There was one postoperative death (after a Belsey Mark IV repair). The cumulative recurrence rate after the Nissen operation was 9%, all recurrences of oesophagitis occurring within the first two years. The cumulative recurrence after the Belsey repair was 37%. Only 15 of 32 patients treated with Nissen fundoplication for stricture needed dilatation after operation, and then only during the first two years. "Gas-bloat" occurred in 18% of the patients treated with Nissen fundoplication. We conclude that the Nissen fundoplication is a good operation for patients with severe reflux oesophagitis and for those with peptic strictures of the oesophagus. The Belsey Mark IV repair, however, cannot be recommended for patients with strictures.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app